DePuy Synthes, in collaboration with LifeNet Health, launched ViviGen Formable™ Cellular Bone Matrix in February, a second generation cellular allograft used to assist in the formation of bone during spinal fusion surgery.
ViviGen Formable augments the DePuy Synthes biomaterials portfolio and joins the first generation, ViviGen Cellular Bone Matrix, which launched in late 2014. Surgeons may now choose a preferred handling option based on the needs of each surgical case.
ViviGen Formable contains osteoinductive, demineralised fibres that create a putty-like consistency. The fibres interconnect to achieve the formable handling favoured in open void cases such as posterolateral fusion, a common type of spinal fusion surgery. This unique handling helps surgeons mould the allograft into a defined shape.
“ViviGen Formable has a great consistency, which allows it to be packed into the openings of the posterolateral spine,” said Thomas Morrison, of Polaris Spine and Neurosurgery in Atlanta. “The handling characteristics deliver confidence that the fusion bed is well packed and grafted for fusion.”
Both ViviGen and ViviGen Formable represent a paradigm shift in the field of bone repair by focusing on protecting viable, lineage committed bone cells from recovery to implantation while retaining all three properties required for bone formation, osteoinductivity, osteoconductivity and osteogenecity. ViviGen is now being used in a wide variety of trauma procedures for the repair or reconstruction of musculoskeletal defects and is currently only available in the USA.
For details, visit DePuy Synthes